AltMountain

Abingworth Clinical Co-Development Fund LP

London, United Kingdom · CIK 1658235
Offshore
Status: no Form D since Nov 2015. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Abingworth Clinical Co-Development Fund LP is a venture capital fund based in London, United Kingdom. Its most recent Form D, filed Nov 23, 2015, reports no sales yet. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include General Partner Abingworth Clinical Co-Development Fund GP LP; Manager Abingworth LLP.

Total raised
$0Cumulative sales reported on Form D
Investors
0
First sale
—
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
General Partner Abingworth Clinical Co-Development Fund GP LP; Manager Abingworth LLP
Latest Form D
Nov 23, 2015

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌‌‌⁠

Questions about Abingworth Clinical Co-Development Fund LP

What is the minimum investment for Abingworth Clinical Co-Development Fund LP?

Abingworth Clinical Co-Development Fund LP's latest Form D, filed Nov 23, 2015, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Abingworth Clinical Co-Development Fund LP?

Abingworth Clinical Co-Development Fund LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Abingworth Clinical Co-Development Fund LP raised?

Abingworth Clinical Co-Development Fund LP's latest Form D, filed Nov 23, 2015, reports no sales yet.

Where is Abingworth Clinical Co-Development Fund LP based?

Abingworth Clinical Co-Development Fund LP is based in London, United Kingdom.

Size compared with every venture capital fund

This fund hasn't reported any sales yet.

More venture capital funds in London

Recently filed venture capital funds in United Kingdom

All venture capital funds in United Kingdom